tiotropium+olodaterol

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

Pulmonary Disease, Chronic Obstructive

Phase 3

To Evaluate the Effect of Inhaled Medication Together With Exercise and Activity Training on Exercise Capacity and Daily Activities in Patients With Chronic Lung Disease With Obstruction of Airways

CompletedNCT02085161

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2014-03-31End: 2015-10-31Updated: 2017-01-06

Unknown Phase

Safety of Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease (COPD) Patients in Taiwan: a Non-interventional Study Based on the Taiwan National Health Insurance (NHI) Data

CompletedNCT05393245

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2022-09-30End: 2022-12-07Updated: 2024-12-04

Related Papers

Effect of Bronchodilation, Exercise Training, and Behavior Modification on Symptoms and Physical Activity in Chronic Obstructive Pulmonary Disease

American Journal of Respiratory and Critical Care Medicine2018-04-1799 citations

Effects of bronchodilator therapy and exercise with self-management behaviour-modification on psychological and cognitive outcomes in COPD

2017-09-013 citations

Impact of meeting behavioral targets in a self-management behaviour-modification program designed to improve physical activity in COPD patients

2017-09-01

Effect of 8 and 12 weeks' once-daily tiotropium and olodaterol, alone and combined with exercise training, on exercise endurance during walking in patients with COPD

Pneumologie2017-02-232 citations

S34 Effect of 8 and 12 weeks’ once-daily tiotropium and olodaterol, alone and combined with exercise training, on exercise endurance during walking in patients with copd

Thorax2016-11-151 citations

Effect of 8 and 12 weeks' once-daily tiotropium and olodaterol, alone and combined with exercise training, on exercise endurance during walking in patients with COPD

2016-09-012 citations

LATE-BREAKING ABSTRACT: Effects of bronchodilator therapy and exercise training, added to a self-management behaviour-modification programme, on physical activity in COPD

2016-09-01

Enhancing exercise tolerance and physical activity in COPD with combined pharmacological and non-pharmacological interventions: PHYSACTO randomised, placebo-controlled study design

BMJ Open2016-04-0139 citations

Behaviour-change intervention in a multicentre, randomised, placebo-controlled COPD study: methodological considerations and implementation

BMJ Open2016-04-0127 citations